Meibomian Gland Dysfunction, Ocular Surface Disease, Palpebral Pathologies
Conditions
Keywords
MGD, ocular surface pathologies
Brief summary
The purpose of this study is to determine the incidence and characteristics of eyelid inflammatory disorders during general ophthalmological consultations and to demonstrate association between palpebral pathologies and ocular surface pathologies.
Interventions
None listed
Sponsors
Iris Pharma
Axial Biotech, Inc
Laboratoires Thea
Study design
Observational model
ECOLOGIC_OR_COMMUNITY
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Outpatients of either sex, aged at least 18 years, seen in general ophthalmological consultation * Patients informed of the objectives of the survey and agreeing to participate. * Patient attending to the ophthalmological consultation for any reasons: regular check-up of chronic disease, acute symptoms, or for surgery preparation or follow up.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Incidence of eyelid disorders in general ophthalmological practice | Day 1 | * Systematic description of the eyelid, the ocular surface and the dermatological aspect of the face * Occurrence of Meibomian Gland Dysfunction(MGD). |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Association between palpebral pathologies and ocular surface pathologies | Day 1 | To describe association between palpebral pathologies and ocular surface pathologies |
| Impact of eyelid disorder on patient's daily life | Day 1 | Consequences on vision, on daily life activities/work, on leisure, on contact lens wearing, on emotions, on sleeping, |
| Current recommended strategy to treat eyelids disorders | Day 1 | Description of recommended strategy |
Countries
Germany, Spain
Outcome results
None listed